STOCK TITAN

[Form 4] Enova International, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Enova International, Inc. (ENVA) director Linda Johnson Rice purchased 1,700 shares of Enova common stock on 09/10/2025 at a reported price of $115.9471 per share. After this purchase she beneficially owned 6,257 shares.

The Form 4 was filed as a single reporting person filing and is signed by an attorney in fact, Sean Rahilly, dated 09/12/2025. The filing reports a straightforward open-market purchase by an insider; no derivative transactions or amendments are included.

Enova International, Inc. (ENVA) la direttrice Linda Johnson Rice ha acquistato 1.700 azioni ordinarie di Enova in data 09/10/2025 al prezzo riportato di $115.9471 per azione. Dopo questo acquisto detiene beneficiariamente 6.257 azioni.

Il Form 4 è stato registrato come una sola persona dichiarante e è firmato da un procuratore, Sean Rahilly, datato 09/12/2025. La segnalazione riferisce un semplice acquisto sul mercato da parte di un insider; non sono inclusi strumenti derivati o emendamenti.

Enova International, Inc. (ENVA) la directora Linda Johnson Rice compró 1.700 acciones ordinarias de Enova el 09/10/2025 a un precio reportado de $115.9471 por acción. Tras esta compra poseía 6.257 acciones a título de beneficiaria.

El Formulario 4 se presentó como una única persona reportante y está firmado por un apoderado, Sean Rahilly, con fecha 09/12/2025. El informe señala una compra directa en el mercado por parte de una persona insider; no se incluyen transacciones derivadas ni enmiendas.

Enova International, Inc. (ENVA) 이사인 Linda Johnson Rice가 2025년 9월 10일 Enova 일반주 1,700주를 보고된 주당 가격 115.9471달러에 매수했습니다. 이 매수 이후 그녀는 총 6,257주를 실질적으로 보유하게 되었습니다.

제4폼은 단일 보고자 제출로 작성되었으며 대리인 Sean Rahilly가 서명했고 날짜는 2025년 9월 12일입니다. 이 제출은 내부자가 일반 거래 시장에서 매수한 것을 단순히 보고한 것으로, 파생거래나 수정사항은 포함되어 있지 않습니다.

Enova International, Inc. (ENVA) la directrice Linda Johnson Rice a acheté 1 700 actions ordinaires de Enova le 10/09/2025 au prix indiqué de 115,9471 $ par action. Suite à cet achat, elle détenait bénéficiairement 6 257 actions.

Le Formulaire 4 a été déposé en tant que personne déclarante unique et est signé par un mandataire, Sean Rahilly, daté du 12/09/2025. Le dépôt rapporte un achat simple sur le marché par un initié ; aucune transaction dérivée ni amendement n’est inclus.

Enova International, Inc. (ENVA) Vorstandmitglied Linda Johnson Rice kaufte am 09/10/2025 1.700 Stammaktien von Enova zu einem gemeldeten Kurs von 115,9471 $ pro Aktie. Nach diesem Kauf hielt sie anschließend 6.257 Aktien rechenschaftspflichtig.

Das Formblatt 4 wurde als einzelne meldende Person eingereicht und ist von einem Bevollmächtigten, Sean Rahilly, datiert auf 12/09/2025, unterzeichnet. Die Einreichung meldet einen einfachen Open-Market-Kauf durch einen Insider; es sind keine Derivategeschäfte oder Änderungsanträge enthalten.

إنوفا الدولية، شركة مساهمة (Enova International, Inc. (ENVA)) قامت المديرة ليندا جونسون رايس بشراء 1,700 سهماً من الأسهم العادية لشركة Enova في 09/10/2025 بسعر مفصح عنه قدره 115.9471 دولاراً للسهم الواحد. بعد هذه الشراء أصبحت تمتلك بشكل مفعَّل 6,257 سهماً.

تم تقديم النموذج 4 كمقدِّم تقرير واحد وهو موقع من قبل الوكيل Sean Rahilly، وتاريخه 09/12/2025. التقرير يذكر شراءاً مباشراً في السوق من قبل مطلع/مطلع داخلي؛ لا توجد معاملات مشتقة أو تعديلات مرفقة.

Enova International, Inc. (ENVA) 董事 Linda Johnson Rice 于 2025/09/10 以每股披露价格 $115.9471 购买了 1,700 股 Enova 普通股。此次购买后,她实际持有 6,257 股。

Form 4 被以单一申报人提交,并由授权代理 Sean Rahilly 签名,日期为 2025/09/12。该申报报告了一项由内部人士在公开市场的直接购买;未包含衍生交易或修订。

Positive
  • Insider purchase disclosed: Director Linda Johnson Rice acquired 1,700 shares, increasing her direct ownership to 6,257 shares.
  • Clear, single-person filing: Form filed by one reporting person and signed via attorney-in-fact, indicating procedural compliance.
Negative
  • None.

Insights

TL;DR: Director purchase reported; routine insider buy with no derivatives or amendments.

This Form 4 documents a direct purchase by a board director, which is a standard disclosure under Section 16. The report shows the director increased her direct beneficial holding to 6,257 shares via a 1,700-share purchase at $115.9471 each. Filing as one reporting person and signature by an attorney-in-fact are procedural details consistent with proper Section 16 reporting.

TL;DR: Insider bought shares; transaction size is modest relative to typical institutional holdings.

The acquisition is a non-derivative purchase executed on 09/10/2025. The form contains no information on intent, plans, or material corporate events. From a disclosure perspective, this is a routine insider purchase that increases the director's direct stake to 6,257 shares.

Enova International, Inc. (ENVA) la direttrice Linda Johnson Rice ha acquistato 1.700 azioni ordinarie di Enova in data 09/10/2025 al prezzo riportato di $115.9471 per azione. Dopo questo acquisto detiene beneficiariamente 6.257 azioni.

Il Form 4 è stato registrato come una sola persona dichiarante e è firmato da un procuratore, Sean Rahilly, datato 09/12/2025. La segnalazione riferisce un semplice acquisto sul mercato da parte di un insider; non sono inclusi strumenti derivati o emendamenti.

Enova International, Inc. (ENVA) la directora Linda Johnson Rice compró 1.700 acciones ordinarias de Enova el 09/10/2025 a un precio reportado de $115.9471 por acción. Tras esta compra poseía 6.257 acciones a título de beneficiaria.

El Formulario 4 se presentó como una única persona reportante y está firmado por un apoderado, Sean Rahilly, con fecha 09/12/2025. El informe señala una compra directa en el mercado por parte de una persona insider; no se incluyen transacciones derivadas ni enmiendas.

Enova International, Inc. (ENVA) 이사인 Linda Johnson Rice가 2025년 9월 10일 Enova 일반주 1,700주를 보고된 주당 가격 115.9471달러에 매수했습니다. 이 매수 이후 그녀는 총 6,257주를 실질적으로 보유하게 되었습니다.

제4폼은 단일 보고자 제출로 작성되었으며 대리인 Sean Rahilly가 서명했고 날짜는 2025년 9월 12일입니다. 이 제출은 내부자가 일반 거래 시장에서 매수한 것을 단순히 보고한 것으로, 파생거래나 수정사항은 포함되어 있지 않습니다.

Enova International, Inc. (ENVA) la directrice Linda Johnson Rice a acheté 1 700 actions ordinaires de Enova le 10/09/2025 au prix indiqué de 115,9471 $ par action. Suite à cet achat, elle détenait bénéficiairement 6 257 actions.

Le Formulaire 4 a été déposé en tant que personne déclarante unique et est signé par un mandataire, Sean Rahilly, daté du 12/09/2025. Le dépôt rapporte un achat simple sur le marché par un initié ; aucune transaction dérivée ni amendement n’est inclus.

Enova International, Inc. (ENVA) Vorstandmitglied Linda Johnson Rice kaufte am 09/10/2025 1.700 Stammaktien von Enova zu einem gemeldeten Kurs von 115,9471 $ pro Aktie. Nach diesem Kauf hielt sie anschließend 6.257 Aktien rechenschaftspflichtig.

Das Formblatt 4 wurde als einzelne meldende Person eingereicht und ist von einem Bevollmächtigten, Sean Rahilly, datiert auf 12/09/2025, unterzeichnet. Die Einreichung meldet einen einfachen Open-Market-Kauf durch einen Insider; es sind keine Derivategeschäfte oder Änderungsanträge enthalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RICE LINDA JOHNSON

(Last) (First) (Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600

(Street)
CHICAGO IL 60604

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.00001 per share 09/10/2025 P 1,700 A $115.9471 6,257 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Sean Rahilly, attorney in fact 09/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ENVA director Linda Johnson Rice report on Form 4?

She reported a non-derivative purchase of 1,700 shares of Enova common stock on 09/10/2025 at a price of $115.9471 per share, resulting in beneficial ownership of 6,257 shares.

Was the Form 4 for ENVA filed by multiple reporting persons?

No. The filing indicates Form filed by one reporting person.

Were any derivative securities reported in this ENVA Form 4?

No. Table II for derivative securities contains no reported transactions.

Who signed the ENVA Form 4 and when?

The form is signed by Sean Rahilly, attorney in fact, dated 09/12/2025.

What was the transaction code listed for the ENVA purchase?

The transaction code reported for the purchase is P.
Enova Intl Inc

NYSE:ENVA

ENVA Rankings

ENVA Latest News

ENVA Latest SEC Filings

ENVA Stock Data

2.88B
23.82M
4.72%
99.13%
7.8%
Credit Services
Personal Credit Institutions
Link
United States
CHICAGO